BIOMAT Database Logo BIOMAT Database Logo

Examination of general and tumor-specific cell-mediated immune responses in mice bearing progressively growing plasmacytomas. 1977

M L Padarathsingh, and J L McCoy, and J H Dean, and D D Lewis, and J W Northing, and L W Law

UI MeSH Term Description Entries
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008934 Mitogens Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed) Mitogen,Phytomitogen,Phytomitogens
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D010954 Plasmacytoma Any discrete, presumably solitary, mass of neoplastic PLASMA CELLS either in BONE MARROW or various extramedullary sites. Plasma Cell Tumor,Plasmocytoma,Plasma Cell Tumors,Plasmacytomas,Plasmocytomas,Tumor, Plasma Cell,Tumors, Plasma Cell
D005260 Female Females

Related Publications

M L Padarathsingh, and J L McCoy, and J H Dean, and D D Lewis, and J W Northing, and L W Law
Curculigoside augments cell-mediated immune responses in metastatic tumor-bearing animals.
August 2016, Immunopharmacology and immunotoxicology,
M L Padarathsingh, and J L McCoy, and J H Dean, and D D Lewis, and J W Northing, and L W Law
Correlation of tumor growth and cell-mediated immune responses of mice bearing mammary tumors following surgical procedures.
November 1975, Journal of the Reticuloendothelial Society,
M L Padarathsingh, and J L McCoy, and J H Dean, and D D Lewis, and J W Northing, and L W Law
Augmentation of specific cell-mediated immune responses to tumor cells in tumor-bearing rats pretreated wih the antileukemia drug busulfan.
April 1981, Journal of the National Cancer Institute,
M L Padarathsingh, and J L McCoy, and J H Dean, and D D Lewis, and J W Northing, and L W Law
Immune response to an allogeneic progressively growing solid tumor.
June 1976, Cancer research,
M L Padarathsingh, and J L McCoy, and J H Dean, and D D Lewis, and J W Northing, and L W Law
Effect of low-dose cyclophosphamide therapy on specific and nonspecific T cell-dependent immune responses of spleen cells from mice bearing large MOPC-315 plasmacytomas.
January 1988, Cancer immunology, immunotherapy : CII,
M L Padarathsingh, and J L McCoy, and J H Dean, and D D Lewis, and J W Northing, and L W Law
K cell cytotoxicity against antibody-coated chicken erythrocytes in tumor-bearing mice: its development with progressively growing tumor and the effect of immunization against the tumor.
February 1976, Journal of immunology (Baltimore, Md. : 1950),
M L Padarathsingh, and J L McCoy, and J H Dean, and D D Lewis, and J W Northing, and L W Law
Effect of Aerva lanata on cell-mediated immune responses and cytotoxic T-lymphocyte generation in normal and tumor-bearing mice.
January 2012, Journal of immunotoxicology,
M L Padarathsingh, and J L McCoy, and J H Dean, and D D Lewis, and J W Northing, and L W Law
Immune responses of DBA/2 mice bearing melanoma tumors: cell-mediated immune responses after challenge with vaccinia virus.
January 1983, Cancer immunology, immunotherapy : CII,
M L Padarathsingh, and J L McCoy, and J H Dean, and D D Lewis, and J W Northing, and L W Law
Plasma-derived MHC class II+ exosomes from tumor-bearing mice suppress tumor antigen-specific immune responses.
July 2012, European journal of immunology,
M L Padarathsingh, and J L McCoy, and J H Dean, and D D Lewis, and J W Northing, and L W Law
Restoration by levamisole of immune responses suppressed in tumor-bearing mice.
January 1983, Cancer immunology, immunotherapy : CII,
Copied contents to your clipboard!